[go: up one dir, main page]

WO2013175970A1 - Récipient médical - Google Patents

Récipient médical Download PDF

Info

Publication number
WO2013175970A1
WO2013175970A1 PCT/JP2013/063018 JP2013063018W WO2013175970A1 WO 2013175970 A1 WO2013175970 A1 WO 2013175970A1 JP 2013063018 W JP2013063018 W JP 2013063018W WO 2013175970 A1 WO2013175970 A1 WO 2013175970A1
Authority
WO
WIPO (PCT)
Prior art keywords
container
drug container
puncture needle
communication
holding member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2013/063018
Other languages
English (en)
Japanese (ja)
Inventor
田中　新也
一郎 脇岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP2014516745A priority Critical patent/JP6128121B2/ja
Publication of WO2013175970A1 publication Critical patent/WO2013175970A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/2013—Piercing means having two piercing ends
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2055—Connecting means having gripping means

Definitions

  • the present invention relates to a medical container, and more specifically, a powder preparation, a freeze-dried preparation, a solid preparation and other dry drugs, and a solution that dissolves the dry drug is stored and used separately.
  • the present invention relates to a medical container used when a dry medicine and a solution are mixed in an infusion container immediately before being supplied as a liquid medicine.
  • the medical container disclosed in each patent document is commonly called a “half kit”, and a communicating member equipped with a double-ended needle having a hollow conduit is attached to an infusion container storing a solution.
  • the communicating member moves to the infusion container side, the puncture needle on one side of the double-ended needle is pierced by the drug container, and the other side of the double-ended needle The puncture needle is pierced through the infusion container.
  • the puncture needle is disengaged from the center of the elastic closure membrane when the double-needle puncture needle is inserted into the elastic closure membrane (rubber plug) provided in the drug container. May be pierced to a different location.
  • the puncture needle is not pierced perpendicularly to the elastic closure membrane, and the puncture needle is pierced in a state inclined with respect to the elastic closure membrane (so-called “oblique puncture”).
  • the medical container disclosed in each of the above patent documents does not employ a structure suitable for returning the communication member to the original position after the communication member has moved to the infusion container side.
  • an aspect of the present invention is to provide a medical container having a structure in which a solution in an infusion container does not leak to the outside.
  • Another aspect of the object of the present invention is to provide a medical container having a structure suitable for preparing a liquid medicine by dissolving a plurality of drugs in a solution.
  • the medical device provided with the infusion container which has a solution inside, and the connection member which is attached to the said infusion container and connects the medicine container which has a dry medicine inside to the said infusion container
  • the container has the following configuration.
  • the drug container includes a container body that contains the dry drug and has an opening, and a closing member that is attached to the opening and closes the opening with an elastic closing film.
  • the connecting member includes a cylindrical portion having an open portion on one end side and a connecting portion communicating with the infusion container on the other end side, and the infusion passage leading to the inside of the infusion container and the infusion passage are closed in the connecting portion.
  • a guide cylindrical member provided with a passage closing membrane, and accommodated inside the guide cylindrical member so as to be movable between the open portion side and the connecting portion side, and the elastic closure membrane of the drug container is A drug container holding member for holding the closing member so that the posture of the container main body is maintained in a state of facing the infusion container side; and the guide cylinder movably between the connecting portion and the drug container holding member.
  • a communicating member that is housed inside the shaped member and has a double-ended needle.
  • the double-ended needle extends toward the open portion and is pierced by the elastic closure membrane, and the second puncture needle extends toward the passage closure membrane and penetrates the passage closure membrane. And a hollow conduit that communicates the inside of the first puncture needle and the inside of the second puncture needle, and the closing member of the medicine container is held by the medicine container holding member.
  • the first puncture needle is pierced by the elastic closure membrane by pushing the drug container and the drug container holding member toward the connecting portion side of the guide cylindrical member, and the communication member is The second puncture needle is pierced through the passage closing membrane by being pushed toward the infusion container.
  • an engagement structure for maintaining the state where the second puncture needle of the communication member is pierced by the passage closing membrane is provided between the communication member and the inner surface of the tubular portion. Provided.
  • an elastic member is used for the passage closing membrane, and the drug container holding member and the communication member are integrally connected between the drug container holding member and the communication member.
  • connection structure The connection between the communication member and the inner surface of the cylindrical portion is released between the drug container holding member and the communication member by the connection structure, and the communication member is held on the inner surface of the cylindrical portion.
  • the holding structure is provided, and after the second puncture needle is released from the passage closing membrane, the drug container holding member and the communication member are moved to the opening portion side of the guide cylindrical member.
  • the connection between the drug container holding member and the communication member is released by the holding structure, and the communication member is held on the inner surface of the cylindrical portion to hold the drug container. Only the drug container holding member moves to the open part side, and the piercing of the first puncture needle into the elastic closure membrane is released.
  • the medical container based on the present invention it is possible to provide a medical container having a structure in which the solution in the infusion container does not leak to the outside. According to another aspect of the medical container based on the present invention, it is possible to provide a medical container having a structure suitable for adjusting a liquid medicine by dissolving a plurality of drugs in a solution.
  • FIG. 1 is a front view showing an overall structure of a medical container in Embodiment 1.
  • FIG. 1 is a perspective view showing an overall structure of a medical container in Embodiment 1.
  • FIG. It is a perspective view which shows the structure of a chemical
  • FIG. 3 is an exploded perspective view showing a structure of a connecting member in the first embodiment.
  • FIG. 6 is a first longitudinal sectional view showing a communication operation using the medical container and the medicine container in the first embodiment.
  • FIG. 10 is a second longitudinal sectional view showing a communication operation using the medical container and the medicine container in the first embodiment.
  • FIG. 10 is a third longitudinal sectional view showing a communication operation using the medical container and the medicine container in the first embodiment.
  • FIG. 10 is a fourth longitudinal sectional view showing a communication operation using the medical container and the drug container in the first embodiment.
  • FIG. 10 is a fifth longitudinal sectional view showing a communication operation using the medical container and the medicine container in the first embodiment. It is a 6th longitudinal cross-sectional view which shows communication operation using the medical container and chemical
  • FIG. 10 is a first vertical cross-sectional view showing a communication operation using a medical container and a drug container in the second embodiment.
  • FIG. 10 is a second longitudinal sectional view showing a communication operation using the medical container and the medicine container in the second embodiment.
  • FIG. 10 is a third longitudinal sectional view showing a communication operation using the medical container and the medicine container in the second embodiment.
  • FIG. 12 is a fourth longitudinal sectional view showing a communication operation using the medical container and the medicine container in the second embodiment.
  • FIG. 10 is a fifth longitudinal sectional view showing a communication operation using the medical container and the medicine container in the second embodiment. It is a 6th longitudinal cross-sectional view which shows communication operation using the medical container and chemical
  • FIG. 1 is a front view showing the entire structure of the medical container in the present embodiment
  • FIG. 2 is a perspective view showing the entire structure of the medical container in the present embodiment
  • FIG. 3 shows the structure of the drug container.
  • FIG. 4 is an exploded perspective view showing the structure of the connecting member in the present embodiment. In FIG. 4, a partly broken view is shown for easy understanding of the internal structure.
  • medical container 1 includes infusion container 100 having a solution S therein, and a medicine that is attached to infusion container 100 and has dry medicine D therein.
  • a connecting member 300 for connecting the container 500 (see FIG. 3) to the infusion container 100 is provided.
  • the solution S distilled water, physiological saline, glucose solution and the like are generally used, but are not limited thereto.
  • the infusion container 100 a bottle that can be pressed and deformed formed of a relatively soft synthetic resin such as polyethylene, polypropylene, or polyester is usually used.
  • a connecting member 300 is connected to the upper part of the infusion container 100, and a dissolution liquid outlet (not shown) and a cover member 200 for closing the dissolution liquid outlet are attached to the lower part of the infusion container 100.
  • a drug container 500 contains a dry drug D, a container body 501 having an opening 502, and a closing member 510 that is attached to the opening 502 and closes the opening 502 with an elastic closing film 510s.
  • a glass container or a resin container is used for the container body 501.
  • the elastic sealing film 510s is caulked with a metal material or reinforced with a resin material so that the elastic closing film 510s does not fall off from the opening 502.
  • a rubber member or the like is used for the elastic closing film 510s.
  • the elastic closing film 510s can close the opening 502 again even when the needle is removed after the needle has been punctured.
  • the connecting member 300 will be described in detail with reference to FIG.
  • the connecting member 300 includes a guide cylindrical member 301 and a drug container holding member 310 and a communication member 350 accommodated in the guide cylindrical member 301.
  • the guide tubular member 301 includes a tubular portion 301a having an open portion 301b on one end side (upper end side in the drawing) and a connecting portion 301c communicating with the infusion container 100 on the other end side (lower end side in the drawing).
  • the connecting portion 301c is provided with an infusion passage 301d communicating with the inside of the infusion container 100 and a passage closing film 301s for closing the infusion passage 301d.
  • the open portion 301b is sealed with sterilized paper or the like before use, and is used after being peeled off.
  • the guide cylindrical member 301 and the passage closing film 301s are formed of a flexible resin such as polyethylene, polypropylene, polyester, polyvinyl chloride, and polycarbonate ABS resin.
  • a total of eight streaky convex guide walls R11 extending from the open portion 301b toward the connecting portion 301c are formed at a 45 degree pitch on the circumference.
  • GIP2 is defined.
  • the first guide inner peripheral surface GIP1 and the second guide inner peripheral surface GIP2 are provided alternately.
  • the first guide inner circumferential surface GIP1 prevents the drug container holding member 310 from rotating and guides the movement of the drug container holding member 310 between the open portion 301b side and the connecting portion 301c side.
  • the second guide inner peripheral surface GIP2 prevents the communication member 350 from rotating and guides the movement of the communication member 350 between the open portion 301b side and the connection portion 301c side.
  • the first guide inner circumferential surface GIP1 is provided with a first rib R100 extending in the circumferential direction on the open portion 301b side.
  • the first rib R100 is used for positioning the drug container holding member 310.
  • the second guide inner peripheral surface GIP2 is provided with a second rib R200 and a third rib R300 extending in the circumferential direction and arranged at a predetermined interval in an intermediate region between the opening portion 301b and the connecting portion 301c. Yes.
  • the second rib R200 and the third rib R300 are used for positioning the communication member 350.
  • the drug container holding member 310 is accommodated inside the guide cylindrical member 301 so as to be movable between the open part 301b side and the connecting part 301c side, and the elastic closure film 510s of the drug container 500 faces the infusion container 100 side.
  • the closing member 510 is held so that the posture of the container body 501 is maintained in the state.
  • the specific configuration of the drug container holding member 310 includes a circular base portion 311 provided with an opening 311h in the center and a cylindrical upright wall 312 rising from the periphery of the base portion 311.
  • an engaging wall 313 extending from the standing wall 312 and having an engaging claw 313 a that engages with the closing member 510 of the drug container 500 is formed on the inner surface side at a pitch of 90 degrees on the circumference. A total of four locations are provided.
  • auxiliary walls 314 are provided between the engaging walls 313 at a pitch of 90 degrees on the circumference.
  • the quantity of the engaging wall 313 and the auxiliary wall 314 is not limited to four places, and is appropriately selected.
  • An arm portion 315 projecting outward is provided on the outer peripheral surface of the standing wall 312.
  • a sliding portion 316 provided in parallel with the standing wall 312 is provided on the distal end side of the arm portion 315.
  • the drug container holding member 310 is made of polyethylene, polypropylene, polyester, polyvinyl chloride, polycarbonate ABS resin, or the like, and is formed by integral formation.
  • both sides of the sliding portion 316 are sandwiched between the convex guide walls R11, and the outer peripheral surface of the sliding portion 316 is within the first guide.
  • the medicine container holding member 310 abuts on the peripheral surface GIP1 and slides between the open portion 301b side and the connecting portion 301c side along the first guide inner peripheral surface GIP1.
  • the communication member 350 is housed inside the guide cylindrical member 301 so as to be movable between the connecting portion 301 c and the drug container holding member 310, and has a double-ended needle 356.
  • a circular base portion 351 provided with a double-ended needle 356 in the center portion and arm portions 352 projecting outward from the periphery of the base portion 351 are arranged at a pitch of 90 degrees on the circumference. There are four places in total.
  • a sliding portion 353 provided in parallel with the double-ended needle 356 is provided on the distal end side of the arm portion 352.
  • the double-ended needle 356 extends toward the elastic closure membrane 510s of the drug container 500, and extends toward the first puncture needle 356a pierced by the elastic closure membrane 510s and the passage closure membrane 301s of the guide cylindrical member 301. It has the 2nd puncture needle 356b pierced by the channel
  • the communication member 350 is made of polyethylene, polypropylene, polyester, polyvinyl chloride, polycarbonate ABS resin, or the like, and is formed by integral formation.
  • both sides of the sliding portion 353 are sandwiched between the convex guide walls R11, and the outer peripheral surface of the sliding portion 353 is the second guide inner peripheral surface.
  • the communication member 350 contacts the GIP2 and slides between the open portion 301b side (drug container holding member 310) and the connecting portion 301c side along the second guide inner peripheral surface GIP2.
  • 5 to 10 are first to sixth longitudinal sectional views showing communication operations using the medical container 1 and the medicine container 500 in the present embodiment.
  • first rib R100, the second rib R200, and the third rib R300 do not appear in the same cross section, for convenience of explanation, the first rib R100 and the second rib R200 are shown in the same cross section in FIGS. And the third rib R300 is illustrated.
  • the connecting member 300 is inside the guide cylindrical member 301, and the drug container holding member 310 is the upper end side of the guide cylindrical member 301 by the first rib R ⁇ b> 100.
  • the communication member 350 is positioned at an intermediate position of the guide cylindrical member 301 by the second rib R200.
  • the closing member 510 of the medicine container 500 is firmly held by using the engaging claw 313 a of the medicine container holding member 310 so that the closing member 510 of the medicine container 500 faces the medicine container holding member 310.
  • medical agent container 500 is hold
  • the medicine container 500 and the medicine container holding member 310 are connected to the connecting portion 301 c side (infusion container) of the guide cylindrical member 301. 100), the first puncture needle 356a is pierced through the elastic closure membrane 510s.
  • the arm portion 315 and the sliding portion 316 of the drug container holding member 310 and the arm portion 352 and the sliding portion 353 of the communication member 350 are arranged at positions shifted from each other by 90 degrees.
  • the first puncture needle 356a passes through the opening 311h provided in the base portion 311 of the drug container holding member 310 so that the base portion 311 of the drug container holding member 310 and the base portion 351 of the communication member 350 come into contact with each other.
  • the drug container holding member 310 and the communication member 350 overlap.
  • the communication member 350 is further pushed toward the infusion container 100, whereby the second puncture needle 356b is pierced through the passage closing membrane 301s.
  • the internal space of the drug container 500 and the internal space of the infusion container 100 are in communication with each other by the hollow conduit 356c of the double-ended needle 356.
  • the operations shown in FIGS. 7 and 8 may proceed simultaneously.
  • the medicine container 500 is pushed forward to the infusion container 100 while the posture of the medicine container 500 is held by the medicine container holding member 310, the medicine container 500 is tilted left and right.
  • the first puncture needle 356a can be pierced through the center of the elastic closure film 510s of the drug container 500.
  • the third rib R300 is engaged with the sliding portion 353, and movement of the communication member 350 to the open portion 301b side (infusion container 100 side) is prevented. That is, an engagement structure is formed between the sliding portion 353 of the communication member 350 and the third rib R300 formed on the inner surface of the tubular portion 301a.
  • the communication member 350 remains in that position due to the engagement structure described above, and the piercing of the second puncture needle 356b to the passage closing film 301s is maintained, and only the drug container 500 and the drug container holding member 310 are guide-cylindrical. It moves to the open part 301b side of the member 301. As a result, the first puncture needle 356a is pulled out from the elastic closure film 510s.
  • the drug container 500 is detached from the drug container holding member 310.
  • the medicine container 500 containing different dry medicines can be mounted on the medicine container holding member 310 again, and the different dry medicines and the solution S can be mixed aseptically and supplied as a liquid medicine. .
  • FIGS. 11 to 16 are first to sixth longitudinal sectional views showing communication operations using the medical container 1 and the medicine container 500 in the present embodiment.
  • first rib R100, the second rib R200, and the third rib R300 do not appear in the same cross section, for convenience of explanation, the first rib R100 and the second rib R200 are shown in the same cross section in FIGS. And the third rib R300 is illustrated.
  • the basic configurations of the medical container 1 and the drug container 500 are the same as those in the first embodiment.
  • a connecting structure 600 that integrally connects the drug container holding member 310 and the communication member 350 is employed between the drug container holding member 310 and the communication member 350.
  • the connection between the drug container holding member 310 and the communication member 350 due to the connection structure is released, and the communication member 350 is connected to the inner surface of the cylindrical portion 301a.
  • a holding structure for holding is provided.
  • the arm portion 352 of the communication member 350 is provided with an engagement member 601 toward the drug container holding member 310, and the outer peripheral surface of the standing wall 312 of the drug container holding member 310. Is provided with an engagement recess 602 with which the engagement member 601 is engaged.
  • the third rib R300 is provided on the drug container holding member 310 side with respect to the second rib R200, and the connecting structure 600 is held at the intermediate position of the guide cylindrical member 301 by the second rib R200 and the third rib R300. It is possible.
  • a film made of an elastic member such as a rubber plug is used for the passage closing film 301s so that the solution S does not leak to the outside even when the second puncture needle 356b is inserted or removed. .
  • the connecting member 300 is inside the guide cylindrical member 301, and the drug container holding member 310 is the upper end side of the guide cylindrical member 301 by the first rib R ⁇ b> 100.
  • the communication member 350 is positioned at an intermediate position of the guide cylindrical member 301 by the second rib R200.
  • the closing member 510 of the medicine container 500 is firmly held by using the engaging claw 313a of the medicine container holding member 310 so that the closing member 510 of the medicine container 500 faces the medicine container holding member 310.
  • medical agent container 500 is hold
  • the medicine container 500 and the medicine container holding member 310 are connected to the connecting portion 301 c side (infusion container) of the guide cylindrical member 301. 100), the first puncture needle 356a is pierced through the elastic closure membrane 510s.
  • the arm portion 315 and the sliding portion 316 of the drug container holding member 310 and the arm portion 352 and the sliding portion 353 of the communication member 350 are arranged at positions shifted from each other by 90 degrees.
  • the first puncture needle 356a passes through the opening 311h provided in the base portion 311 of the drug container holding member 310 so that the base portion 311 of the drug container holding member 310 and the base portion 351 of the communication member 350 come into contact with each other.
  • the drug container holding member 310 and the communication member 350 overlap.
  • the engagement member 601 of the communication member 350 is engaged with the engagement recess 602 of the drug container holding member 310, and the communication member 350 and the drug container holding member 310 are integrated.
  • the communication member 350 is further pushed toward the infusion container 100, whereby the second puncture needle 356b is pierced through the passage closing film 301s.
  • the internal space of the drug container 500 and the internal space of the infusion container 100 are in communication with each other by the hollow conduit 356c of the double-ended needle 356.
  • the operations shown in FIGS. 13 and 14 may proceed simultaneously.
  • the medicine container 500 is pushed forward to the infusion container 100 in a state where the posture of the medicine container 500 is held by the medicine container holding member 310, the medicine container 500 is tilted left and right.
  • the first puncture needle 356a can be pierced through the center of the elastic closure film 510s of the drug container 500.
  • connection between the communication member 350 and the inner surface of the cylindrical portion 301a is released between the drug container holding member 310 and the communication member 350 by the connection structure, and the communication member 350 is connected to the inner surface of the cylindrical portion 301a.
  • the above-described holding structure for holding is provided.
  • the drug container holding member 310 and the communication member 350 are connected to the open portion 301b side of the guide cylindrical member 301.
  • the connection between the drug container holding member 310 and the communication member 350 is released by the holding structure described above.
  • the communication member 350 is held on the inner surface of the cylindrical portion 301a, and only the drug container holding member 310 holding the drug container 500 moves to the open portion 301b side, and the first puncture needle 356a is moved to the elastic closure film 510s. The piercing will be cancelled. Thereafter, similarly to FIG. 10, the medicine container 500 is detached from the medicine container holding member 310.
  • the drug container 500 containing different dry drugs is mounted on the drug container holding member 310 again, and the different dry drugs and the solution S are mixed in an aseptic condition to obtain a liquid drug. It is also possible to supply as.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PCT/JP2013/063018 2012-05-23 2013-05-09 Récipient médical Ceased WO2013175970A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014516745A JP6128121B2 (ja) 2012-05-23 2013-05-09 医療用容器

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012117409 2012-05-23
JP2012-117409 2012-05-23

Publications (1)

Publication Number Publication Date
WO2013175970A1 true WO2013175970A1 (fr) 2013-11-28

Family

ID=49623664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/063018 Ceased WO2013175970A1 (fr) 2012-05-23 2013-05-09 Récipient médical

Country Status (2)

Country Link
JP (1) JP6128121B2 (fr)
WO (1) WO2013175970A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015166993A1 (fr) * 2014-05-02 2015-11-05 株式会社ジェイ・エム・エス Connecteur de récipient de médicament et couvercle de composant mâle
CN105997509A (zh) * 2016-07-18 2016-10-12 湖南懿科药用包装材料科技有限公司 可对多剂型进行多次直配的输液容器组合盖及输液容器
CN106074160A (zh) * 2016-07-18 2016-11-09 湖南懿科药用包装材料科技有限公司 可多次直配的输液容器配药器及输液容器
CN106178156A (zh) * 2016-07-18 2016-12-07 湖南懿科药用包装材料科技有限公司 可多次直配的输液容器组合盖及输液容器
CN106178155A (zh) * 2016-07-18 2016-12-07 湖南懿科药用包装材料科技有限公司 可对多剂型进行多次直配的输液容器接口及输液容器
CN106236582A (zh) * 2016-08-26 2016-12-21 湖南懿科药用包装材料科技有限公司 可多次直配的双咀输液容器组合盖及输液容器
WO2018070174A1 (fr) 2016-10-14 2018-04-19 ニプロ株式会社 Récipient
US10596068B2 (en) 2014-05-02 2020-03-24 Jms Co., Ltd. Drug container connector and male member cover

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686738U (ja) * 1992-06-16 1994-12-20 森下ルセル株式会社 医療用容器
US20070088315A1 (en) * 2004-02-04 2007-04-19 Hans Haindl Medical transfer device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000101A1 (fr) * 1993-06-28 1995-01-05 Roussel Morishita Co., Ltd. Recipient a usage medical
JPH08308905A (ja) * 1995-05-23 1996-11-26 Showa Denko Kk 輸液容器

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686738U (ja) * 1992-06-16 1994-12-20 森下ルセル株式会社 医療用容器
US20070088315A1 (en) * 2004-02-04 2007-04-19 Hans Haindl Medical transfer device

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015166993A1 (fr) * 2014-05-02 2015-11-05 株式会社ジェイ・エム・エス Connecteur de récipient de médicament et couvercle de composant mâle
US10596068B2 (en) 2014-05-02 2020-03-24 Jms Co., Ltd. Drug container connector and male member cover
CN105997509A (zh) * 2016-07-18 2016-10-12 湖南懿科药用包装材料科技有限公司 可对多剂型进行多次直配的输液容器组合盖及输液容器
CN106074160A (zh) * 2016-07-18 2016-11-09 湖南懿科药用包装材料科技有限公司 可多次直配的输液容器配药器及输液容器
CN106178156A (zh) * 2016-07-18 2016-12-07 湖南懿科药用包装材料科技有限公司 可多次直配的输液容器组合盖及输液容器
CN106178155A (zh) * 2016-07-18 2016-12-07 湖南懿科药用包装材料科技有限公司 可对多剂型进行多次直配的输液容器接口及输液容器
CN106236582A (zh) * 2016-08-26 2016-12-21 湖南懿科药用包装材料科技有限公司 可多次直配的双咀输液容器组合盖及输液容器
WO2018070174A1 (fr) 2016-10-14 2018-04-19 ニプロ株式会社 Récipient
JPWO2018070174A1 (ja) * 2016-10-14 2019-08-08 ニプロ株式会社 容器
JP7040454B2 (ja) 2016-10-14 2022-03-23 ニプロ株式会社 容器

Also Published As

Publication number Publication date
JP6128121B2 (ja) 2017-05-17
JPWO2013175970A1 (ja) 2016-01-12

Similar Documents

Publication Publication Date Title
JP6128121B2 (ja) 医療用容器
JP5361875B2 (ja) コネクタ組立体
JP6191378B2 (ja) 医療用容器および移注具
JP5656846B2 (ja) 混合器具及び両頭針の刺通方法
US20120313366A1 (en) Connector for containers containing a medicinal active substance
ES2549168T3 (es) Conector para recipientes que contienen un principio activo médico
JPH06239352A (ja) 溶解液注入セット
JP2013252165A (ja) メスコネクタ
KR20130140129A (ko) 의료용 투여 세트
KR100569223B1 (ko) 일체형 수액용기
JPWO2016143362A1 (ja) コネクタ及び医療機器セット
JP2012010930A (ja) 薬剤投与具
JPWO2012140768A1 (ja) 医療用ポート、およびそれを用いた栄養剤用容器並びに栄養剤供給セット
JP2012029723A (ja) 注射針組立体、及び薬剤注射装置
JPWO2011046210A1 (ja) キャップ、およびそれを用いた栄養剤用容器並びに栄養剤供給セット
KR20120087960A (ko) 의료용 용기의 커넥터 세트
JP7266098B2 (ja) 注入システム
ES2908660T3 (es) Un artículo de llenado y procedimientos para el autollenado de un cartucho
WO2014136652A1 (fr) Instrument d'administration de fluide
JP2020074932A (ja) 混注具、及びこれを備えた薬剤容器
JP4793558B2 (ja) 複室収納容器
JP5885751B2 (ja) 医療用容器
JP6318691B2 (ja) 医療用栓体
JP6215550B2 (ja) 液体投与具
JP6391946B2 (ja) 薬液容器

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13793789

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2014516745

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13793789

Country of ref document: EP

Kind code of ref document: A1